19-40394856-G-A

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_181882.3(PRX):​c.3496C>T​(p.Pro1166Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00108 in 1,612,330 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00093 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 3 hom. )

Consequence

PRX
NM_181882.3 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:4

Conservation

PhyloP100: -0.455
Variant links:
Genes affected
PRX (HGNC:13797): (periaxin) This gene encodes a protein involved in peripheral nerve myelin upkeep. The encoded protein contains 2 PDZ domains which were named after PSD95 (post synaptic density protein), DlgA (Drosophila disc large tumor suppressor), and ZO1 (a mammalian tight junction protein). Two alternatively spliced transcript variants have been described for this gene which encode different protein isoforms and which are targeted differently in the Schwann cell. Mutations in this gene cause Charcot-Marie-Tooth neuoropathy, type 4F and Dejerine-Sottas neuropathy. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01178664).
BP6
Variant 19-40394856-G-A is Benign according to our data. Variant chr19-40394856-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 216835.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=5, Benign=1}.
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.0011 (1603/1460076) while in subpopulation MID AF= 0.00468 (27/5768). AF 95% confidence interval is 0.0033. There are 3 homozygotes in gnomad4_exome. There are 805 alleles in male gnomad4_exome subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PRXNM_181882.3 linkuse as main transcriptc.3496C>T p.Pro1166Ser missense_variant 7/7 ENST00000324001.8 NP_870998.2 Q9BXM0-1
PRXNM_001411127.1 linkuse as main transcriptc.3781C>T p.Pro1261Ser missense_variant 7/7 NP_001398056.1
PRXXM_017027047.2 linkuse as main transcriptc.3394C>T p.Pro1132Ser missense_variant 4/4 XP_016882536.1
PRXNM_020956.2 linkuse as main transcriptc.*3701C>T 3_prime_UTR_variant 6/6 NP_066007.1 Q9BXM0-2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PRXENST00000324001.8 linkuse as main transcriptc.3496C>T p.Pro1166Ser missense_variant 7/71 NM_181882.3 ENSP00000326018.6 Q9BXM0-1

Frequencies

GnomAD3 genomes
AF:
0.000927
AC:
141
AN:
152136
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000314
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00183
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000828
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00140
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000980
AC:
244
AN:
248870
Hom.:
1
AF XY:
0.00107
AC XY:
145
AN XY:
135032
show subpopulations
Gnomad AFR exome
AF:
0.000187
Gnomad AMR exome
AF:
0.000897
Gnomad ASJ exome
AF:
0.0000996
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000392
Gnomad FIN exome
AF:
0.000344
Gnomad NFE exome
AF:
0.00159
Gnomad OTH exome
AF:
0.00180
GnomAD4 exome
AF:
0.00110
AC:
1603
AN:
1460076
Hom.:
3
Cov.:
33
AF XY:
0.00111
AC XY:
805
AN XY:
726496
show subpopulations
Gnomad4 AFR exome
AF:
0.000329
Gnomad4 AMR exome
AF:
0.000894
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000325
Gnomad4 FIN exome
AF:
0.000155
Gnomad4 NFE exome
AF:
0.00129
Gnomad4 OTH exome
AF:
0.000944
GnomAD4 genome
AF:
0.000926
AC:
141
AN:
152254
Hom.:
0
Cov.:
32
AF XY:
0.000846
AC XY:
63
AN XY:
74438
show subpopulations
Gnomad4 AFR
AF:
0.000313
Gnomad4 AMR
AF:
0.00183
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000829
Gnomad4 FIN
AF:
0.0000942
Gnomad4 NFE
AF:
0.00140
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.00131
Hom.:
0
Bravo
AF:
0.000763
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.00121
AC:
147

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicJan 16, 2023BP4 -
Likely benign, criteria provided, single submitterclinical testingGeneDxApr 22, 2022See Variant Classification Assertion Criteria. -
Uncertain significance, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesMay 05, 2020The PRX c.3496C>T; p.Pro1166Ser variant (rs147826200) has been previously observed in a cohort of patients with chemotherapy-induced peripheral neuropathy (Beutler 2014). However, genetic variation in PRX has not been clearly demonstrated to be a risk factor for this particular type of acquired neuropathy. This variant is described in the ClinVar database (Variation ID: 216835) and is found in the general population with an overall allele frequency of 0.09% (265/280,240 alleles) in the Genome Aggregation Database. The proline at codon 1166 is moderately conserved and computational analyses (SIFT, PolyPhen-2) predict that this variant is tolerated. Based on the available information, the clinical significance of this variant is uncertain. REFERENCE Beutler AS et al. Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy. Ann Neurol. 2014 Nov;76(5):727-37. -
not specified Uncertain:1Benign:1
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsSep 03, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingGenomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of PhiladelphiaJul 01, 2015- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 11, 2022The p.P1166S variant (also known as c.3496C>T), located in coding exon 4 of the PRX gene, results from a C to T substitution at nucleotide position 3496. The proline at codon 1166 is replaced by serine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species, and serine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Charcot-Marie-Tooth disease type 4F Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Charcot-Marie-Tooth disease Benign:1
Likely benign, criteria provided, single submitterclinical testingMolecular Genetics Laboratory, London Health Sciences Centre-- -
Charcot-Marie-Tooth disease type 4 Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 11, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.12
DANN
Benign
0.47
DEOGEN2
Benign
0.16
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.50
T
M_CAP
Benign
0.0046
T
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.2
L
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.014
Sift
Benign
0.25
T
Sift4G
Benign
0.10
T
Polyphen
0.0090
B
Vest4
0.053
MVP
0.22
MPC
0.69
ClinPred
0.17
T
GERP RS
0.78
Varity_R
0.061
gMVP
0.043

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147826200; hg19: chr19-40900763; API